Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-044166
Filing Date
2025-03-03
Accepted
2025-03-03 16:35:22
Documents
16
Effectiveness Date
2025-03-03

Document Format Files

Seq Description Document Type Size
1 S-8 d208981ds8.htm S-8 58602
2 EX-5.1 d208981dex51.htm EX-5.1 5140
3 EX-23.2 d208981dex232.htm EX-23.2 3205
4 EX-FILING FEES d208981dexfilingfees.htm   iXBRL EX-FILING FEES 47944
5 GRAPHIC g208981dsp1.jpg GRAPHIC 9404
  Complete submission text file 0001193125-25-044166.txt   317014

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d208981dexfilingfees_htm.xml XML 29270
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285505 | Film No.: 25698608
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)